Terbinafine Strong Evidence
Allylamine antifungal that stops ergosterol synthesis in the fungal cell membrane. Oral terbinafine accumulates in the nail plate for months after the treatment course. Complete cure approximately 38% in the FDA label trials (Lamisil prescribing information). The only treatment with Strong-grade evidence for onychomycosis.
Urea (20–40%) Limited Evidence
A keratolytic agent — it breaks down and softens the protein structure of thick nails. At 40%, used under occlusion, it can dissolve infected nail material entirely (chemical avulsion). At lower concentrations, it softens nails for trimming and improves penetration of topical antifungals applied afterward. Found in Kerasal and standalone urea creams.
Undecylenic acid Limited Evidence
A fatty acid antifungal, FDA-approved for topical skin fungal infections. Limited evidence for nail-plate penetration, but no systemic side effects. The active ingredient in Fungi-Nail.
Efinaconazole (Jublia, Rx) Moderate Evidence
Prescription topical with better nail-plate penetration than older lacquers like ciclopirox. Complete cure rate 15–18% (Elewski et al., JAAD 2013). Lower systemic exposure than oral antifungals.
Tea tree oil Limited Evidence
Some in-vitro antifungal activity. Very limited evidence for thick nail treatment. Not recommended as a primary treatment for established onychomycosis.